curacyte.biz curacyte.biz

curacyte.biz

Curacyte

Curacyte GmbH is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. After the sale of its preclinical technology platform for low molecular weight protease inhibitors to The Medicines Company, Curacyte has focussed all its efforts on the development of PHP / Hemoximer. When the pivotal Phase III trial with PHP was terminated for futility, the company has also terminated its efforts in drug development. August, 26th 2011.

http://www.curacyte.biz/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR CURACYTE.BIZ

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

February

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.3 out of 5 with 12 reviews
5 star
9
4 star
1
3 star
0
2 star
0
1 star
2

Hey there! Start your review of curacyte.biz

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

CONTACTS AT CURACYTE.BIZ

Curacyte GmbH

Christof Hettich

Arnu●●●●. 39

C/o Do●●●●●●h GmbH

Mue●●●hen , 80636

Germany DE

49.8●●●●0681
st●●●●●●●●●●●●●●@curacyte.com

View this contact

Curacyte GmbH

Christof Hettich

Arnu●●●●. 39

C/o Do●●●●●●h GmbH

Mue●●●hen , 80636

Germany DE

49.8●●●●0681
st●●●●●●●●●●●●●●@curacyte.com

View this contact

1&1 Internet AG

Hostmaster EINSUNDEINS

Brau●●●●. 48

Kar●●●uhe , 76135

Germany DE

49.●●●600
49.72●●●●●74248
ho●●●●●●●●@1und1.de

View this contact

1&1 Internet AG

Hostmaster EINSUNDEINS

Brau●●●●. 48

Kar●●●uhe , 76135

Germany DE

49.●●●600
49.72●●●●●74248
ho●●●●●●●●@1und1.de

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
n/a
UPDATED
n/a
EXPIRATION
n/a

BUY YOUR DOMAIN

Network Solutions®

NAME SERVERS

1
ns-de.1and1-dns.de
2
ns-de.1and1-dns.biz

REGISTRAR

1&1 INTERNET AG

1&1 INTERNET AG

WHOIS : whois.neulevel.biz

REFERRED :

CONTENT

SCORE

6.2

PAGE TITLE
Curacyte | curacyte.biz Reviews
<META>
DESCRIPTION
Curacyte GmbH is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. After the sale of its preclinical technology platform for low molecular weight protease inhibitors to The Medicines Company, Curacyte has focussed all its efforts on the development of PHP / Hemoximer. When the pivotal Phase III trial with PHP was terminated for futility, the company has also terminated its efforts in drug development. August, 26th 2011.
<META>
KEYWORDS
1 profile
2 imprint
3 news
4 coupons
5 reviews
6 scam
7 fraud
8 hoax
9 genuine
10 deals
CONTENT
Page content here
KEYWORDS ON
PAGE
profile,imprint,news
CONTENT-TYPE
iso-8859-1
GOOGLE PREVIEW

Curacyte | curacyte.biz Reviews

https://curacyte.biz

Curacyte GmbH is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. After the sale of its preclinical technology platform for low molecular weight protease inhibitors to The Medicines Company, Curacyte has focussed all its efforts on the development of PHP / Hemoximer. When the pivotal Phase III trial with PHP was terminated for futility, the company has also terminated its efforts in drug development. August, 26th 2011.

INTERNAL PAGES

curacyte.biz curacyte.biz
1

Curacyte

http://www.curacyte.biz/index.htm

Curacyte GmbH is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. After the sale of its preclinical technology platform for low molecular weight protease inhibitors to The Medicines Company, Curacyte has focussed all its efforts on the development of PHP / Hemoximer. When the pivotal Phase III trial with PHP was terminated for futility, the company has also terminated its efforts in drug development. August, 26th 2011.

2

Curacyte

http://www.curacyte.biz/news_11_08_26.htm

Munich, August, 26th 2011. Phase III Distributive Shock Trial ( PHOENIX trial ) Terminated for Futility. About PHP / Hemoximer:. About the PHOENIX trial:. Efficacy was to be demonstrated by PHP significantly reducing 28-day all-cause mortality. Secondary endpoints include: Survival time, survivor days in the intensive care unit ( ICU ) and time on mechanical ventilation and on vasopressors. Curacyte AG is a biopharmaceutical company dedicated to the development of new therapeutics for acute and critical ...

3

Curacyte

http://www.curacyte.biz/imprint.htm

Registered seat / Sitz der Gesellschaft. 80636 Munich, Germany. Represented by / vertreten durch:. Prof Dr. Christof Hettich, Geschäftsführer. Registration / Handelsregister München HRB 203 263. VAT-ID / Umsatzsteueridentifikationsnummer: DE 198 159 350.

4

Curacyte

http://www.curacyte.biz/press_releases.htm

Munich, August, 26th 2011. Phase III Distributive Shock Trial ( PHOENIX trial ) Terminated for Futility. The PHOENIX trial is a European, placebocontrolled, Phase III study treating patients in catecholamine-resistant, distributive shock with the Nitric Oxide (NO) scavenger PHP / Hemoximer. The study was launched by Curacyte AG in Austria, Belgium, Germany, Spain, The Netherlands and in the United Kingdom in 2009.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

4

OTHER SITES

curacy.net curacy.net

Welcome to nginx!

If you see this page, the nginx web server is successfully installed and working. Further configuration is required. For online documentation and support please refer to nginx.org. Commercial support is available at nginx.com. Thank you for using nginx.

curacy.org curacy.org

curacy | thoughts from the desert

Thoughts from the desert. Healing of Soul and Body. Asymp; Leave a comment. Remember me, O Lord, in Thy Kingdom not unto judgment or condemnation be my partaking of Thy holy mysteries, O Lord, but unto healing of soul and body. From the Liturgy of St John Chrysostom. Rather, this is my thinking about moral injury. The mostly hidden wound of war on combatants and the similarity to our own moral injury as sinful humans. In his book, Killing From the Inside Out. Notes that there were periods during the Good...

curacycafe.blogspot.com curacycafe.blogspot.com

Karen's Curacy Café

The coffee is hot and strong. Thursday, 10 January 2013. Open Letter to Parishioners at the End of My Curacy. At the beginning of a new year most people reflect back over the past year, and look forward with hope to the new year. This new year has arrived the day after my curacy at St. James and Emmanuel ended. And so I look back over the past three-and-a-half years as your curate, and I look forward to the start of something completely new in the future. May God bless you and keep you. Love, Karen.

curacyl.com curacyl.com

CuraCyl concrete curing boxes - Concrete Curing Box | cordless concrete curing box | initial curing | Curacyl | Products

Model TM 9-40 Model TM 5-12 Model S 4-10 Model TM 6-16. HERE COMES WINTER CURING! Protect project Concrete Test Cylinders in. And meet ASTM C-31. Order a CuraCyl and solve this problem. Cure your project's concrete cylinders with affordable. Has become a great way for testing firms to turn their CuraCyl curing boxes into profit! Contractors gladly pay a. Per use or per cylinder fee. In order to have a proper initial curing box on site. You set the price! Simply put, RUGGED! Don't be a Victim! Featured al...

curacyte.biz curacyte.biz

Curacyte

Curacyte GmbH is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. After the sale of its preclinical technology platform for low molecular weight protease inhibitors to The Medicines Company, Curacyte has focussed all its efforts on the development of PHP / Hemoximer. When the pivotal Phase III trial with PHP was terminated for futility, the company has also terminated its efforts in drug development. August, 26th 2011.

curacyte.com curacyte.com

Curacyte

Curacyte GmbH is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. After the sale of its preclinical technology platform for low molecular weight protease inhibitors to The Medicines Company, Curacyte has focussed all its efforts on the development of PHP / Hemoximer. When the pivotal Phase III trial with PHP was terminated for futility, the company has also terminated its efforts in drug development. August, 26th 2011.

curacyte.eu curacyte.eu

Curacyte

Curacyte GmbH is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. After the sale of its preclinical technology platform for low molecular weight protease inhibitors to The Medicines Company, Curacyte has focussed all its efforts on the development of PHP / Hemoximer. When the pivotal Phase III trial with PHP was terminated for futility, the company has also terminated its efforts in drug development. August, 26th 2011.

curad.com curad.com

Curad Bandages Official Site

Soothe & Cool. Supports, Wraps & Tapes. Antimicrobial vs. Antibacterial: What’s. We’ve got you covered. State-of-the-art solutions to help you feel and heal your best. HOLDS TIGHT & LETS GO EASY. HELPS STOP MINOR BLEEDING FAST. COOLING RELIEF FOR MINOR. BURNS, SCRAPES and BLISTERS. EXTREME HOLD. TOUGH FABRIC. GLOVES FOR DIRTY, GERMY JOBS. ARM and HAMMER, the ARM and HAMMER logo and the distinctive orange trade dress are the trademarks of Church and Dwight Co., Inc. and used under license by CURAD.

curad.incubatorportal.com curad.incubatorportal.com

Incubator Portal

curadaalma144.blogspot.com curadaalma144.blogspot.com

Cura da Alma

Quarta-feira, 10 de fevereiro de 2016. VISÃO GERAL DE METATRON SOBRE 2016. Arcanjo Metatron através de James Tyberonn, dezembro de 2015. Saudações, Mestres, Eu sou Metatron, Anjo de Luz, e estou acompanhado, nesta sessão, por Tyberonn do Serviço Cristalino. Nesta reunião, nos foi pedido para falar sobre o ano que vem, o Ano Quatro da Nova Terra – 2016, na sua cronologia linear. TENDÊNCIA DAS INFLUÊNCIAS ASTROLÓGICAS E PLANETÁRIAS EM 2016. Para sermos claros, apresentamos abaixo uma interpretação de códig...